Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

NCT07263438 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Recurrence Tumor

Interventions

DRUG: Trimipramine
BIOLOGICAL: Cohort 1: Atezolizumab
BIOLOGICAL: Bevacizumab
BIOLOGICAL: Cohort 2: Atezolizumab
BIOLOGICAL: Cohort 2: Bevacizumab

Sponsor

Centre Hospitalier Universitaire Vaudois